Arkolith/Insider Trading/MNPR/Form 4

Cittadine Andrew

Chief Operating OfficerMonopar Therapeutics (MNPR) · full profile →Form 4 · filed Jun 17, 2024
Net Buying
Open-Market Buys
$33K
Open-Market Sells
$0
Net Open-Market Flow
$33K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 17, 2024Buy(P)12K$0.90$11K154K
Jun 14, 2024Buy(P)12K$0.93$11K142K
Jun 13, 2024Buy(P)12K$0.91$11K130K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-24-020547) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML